Agilent Genomics Portfolio Product Leaflet

About this manual

This document outlines Agilent's expanded genomics portfolio, which combines the strengths of Agilent and Stratagene to provide tools for exploring the genome. The portfolio is designed to support researchers in navigating the complexities of biological discovery with high-quality products and services.

What's inside

• Sample Preparation
• Data Analysis
• Detection and Quantitation
• Stratagene Mx Real-Time PCR Platform
• Agilent DNA Microarray Platform
• Agilent 2100 Bioanalyzer
• Brilliant II Reagents
• MicroRNA QRT-PCR Detection
• Bioanalyzer Instruments
• Bioanalyzer Reagents

Specifications

Frequently asked questions

What is the main benefit of the Agilent and Stratagene combined portfolio?

It brings a portfolio of products and services that help researchers explore the genome on their own terms.

What applications does the Stratagene Mx3005P system accommodate?

It accommodates virtually all fluorescent dyes and chemistries for gene expression analysis, SNP genotyping, pathogen detection, and microarray validation.

What does the Agilent 2100 Bioanalyzer allow for?

It allows the objective measurement of RNA samples using the patented RIN algorithm, size and concentration determination of DNA or protein samples, and measurement of unique cellular events.